Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I.

Klinische Pädiatrie

Volumn 221, Issue 6, 2009, Pages 351-357

  Suttorp, M ^a   Claviez, A ^a   Bader, P ^a   Peters, C ^a   Gadner, H ^a   Ebell, W ^a   Dilloo, D ^a   Kremens, B ^a   Kabisch, H ^a   Fuhrer M ^a   Zintl, F ^a   Gobel U ^a   Klingebiel, T ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADOLESCENT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW PURGING; CHILD; CHRONIC MYELOID LEUKEMIA; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KAPLAN MEIER METHOD; MALE; METHODOLOGY; MORTALITY; PROSPECTIVE STUDY;

ADOLESCENT; ANTINEOPLASTIC AGENTS; BONE MARROW PURGING; CHILD; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; PIPERAZINES; PROSPECTIVE STUDIES; PYRIMIDINES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 77449152581     PISSN: None     EISSN: 14393824     Source Type: Journal    
DOI: 10.1055/s-0029-1239529     Document Type: Article

References (0)